Anti-Smad2 antibody [EP567Y] (ab33875)

Publishing research using ab33875? Please let us know so that we can cite the reference in this datasheet.

ab33875 has been referenced in 14 publications.

  • Wu Y  et al. Autocrine transforming growth factor-ß/activin A-Smad signaling induces hepatic progenitor cells undergoing partial epithelial-mesenchymal transition states. Biochimie 148:87-98 (2018). PubMed: 29544731
  • Sun Q  et al. ENMD-1068 inhibits liver fibrosis through attenuation of TGF-ß1/Smad2/3 signaling in mice. Sci Rep 7:5498 (2017). PubMed: 28710422
  • Arase M  et al. Dynamics of chromatin accessibility during TGF-ß-induced EMT of Ras-transformed mammary gland epithelial cells. Sci Rep 7:1166 (2017). PubMed: 28446749
  • Chen Z  et al. CRL4B(DCAF11) E3 ligase targets p21 for degradation to control cell cycle progression in human osteosarcoma cells. Sci Rep 7:1175 (2017). WB ; Human . PubMed: 28446751
  • Hiramoto H  et al. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep 7:4002 (2017). WB, IF ; Human . PubMed: 28638102
  • Zhang X  et al. Puerarin Attenuates Cardiac Hypertrophy Partly Through Increasing Mir-15b/195 Expression and Suppressing Non-Canonical Transforming Growth Factor Beta (Tgfß) Signal Pathway. Med Sci Monit 22:1516-23 (2016). WB . PubMed: 27145790
  • Ji X  et al. The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis. Sci Rep 5:14131 (2015). PubMed: 26370615
  • Gallo EM  et al. Angiotensin II-dependent TGF-ß signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest 124:448-60 (2014). IF . PubMed: 24355923
  • Chen RY  et al. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells. World J Gastroenterol 20:14895-903 (2014). WB ; Human . PubMed: 25356049
  • Yang J  et al. Epicardial calcineurin-NFAT signals through Smad2 to direct coronary smooth muscle cell and arterial wall development. Cardiovasc Res : (2013). IHC . PubMed: 23946498
  • Zieba A  et al. Intercellular variation in signaling through the TGF-ß pathway and its relation to cell density and cell cycle phase. Mol Cell Proteomics 11:M111.013482 (2012). PubMed: 22442258
  • Guillory B  et al. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer. Am J Pathol 177:2635-44 (2010). IHC-P ; Mouse . PubMed: 20847285
  • Espira L  et al. The basic helix-loop-helix transcription factor scleraxis regulates fibroblast collagen synthesis. J Mol Cell Cardiol 47:188-95 (2009). PubMed: 19362560
  • Di Bartolo DL  et al. KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood 111:4731-40 (2008). PubMed: 18199825


Sign up